HighMark Wealth Management »

Definium Therapeutics shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Definium Therapeutics shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Definium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Definium Therapeutics held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therapeutics by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $265 1 265.00

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Fidelity Covington Trust Msci Hlth Care I (FHLC)
Axogen (AXGN)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Neogenomics Com New (NEO)
Ishares Tr Core S&p Us Vlu (IUSV)
Si-bone (SIBN)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Wells Fargo & Company (WFC)
Ishares Tr Core S&p Mcp Etf (IJH)
Apogee Therapeutics (APGE)
Twist Bioscience Corp (TWST)

View all positions for HighMark Wealth Management

Top funds holding Definium Therapeutics

HighMark Wealth Management

View all funds holding Definium Therapeutics